References
Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Brown BT, McVary KT, Te AE, Gholami SS, Rashid P, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Borges FD, Rukstalis DB (2013) The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T study. J Urol 190:2161–2167
Jones P, Rajkumar GN, Rai BP, Aboumarzouk OM, Cleaveland P, Srirangam SJ, Somani BK (2016) Medium-term outcomes of Urolift (minimum 12 months follow-up): evidence from a systematic review. Urology 97:20–24
Rukstalis D, Rashid P, Bogache WK, Tutrone RF, Barkin J, Chin PT, Woo HH, Cantwell AL, Cowan BE, Bolton DM (2016) 24-month durability after crossover to the prostatic urethral lift from randomised, blind sham. BJU Int 118(Suppl 3):14–22
McAdams S, Funk JT, Navetta AF, El Tayeb MM, Humphreys MR (2017) Holmium laser enucleation of the prostate after prostatic urethral lift surgery: feasibility and technical considerations from a multi-institutional case series. J Endourol 31:774–779
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed on human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants in the study.
Rights and permissions
About this article
Cite this article
Batura, D., Sahibzada, I. TURP in the era of UroLift. Int Urol Nephrol 50, 877–878 (2018). https://doi.org/10.1007/s11255-018-1833-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-018-1833-x